Retatrutide is a triple agonist that simultaneously targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCG (glucagon) receptors. This unique multi-receptor mechanism of action confers significant advantages in treating metabolic disorders.
Tirzepatide is an innovative drug for treating type 2 diabetes and obesity. It achieves a dual mechanism of action by simultaneously activating GLP-1 and GIP receptors, demonstrating significant efficacy in blood glucose control, weight loss, and improvement of metabolic markers. However, attention should be paid to potential side effects such as gastrointestinal issues and specific contraindications.
Business Process
|
|
|
|
|
|
Difference
The core distinction between Retatrutide and Tirzepatide lies in their receptor activation mechanisms and clinical outcomes. Retatrutide demonstrates greater weight-loss potential through triple receptor activation, while Tirzepatide has accumulated more long-term data in glycemic control due to its dual receptor action. Below is a detailed comparison of the two:
► Comparison of Mechanisms of Action
Retatrutide:
Triple receptor agonist: Simultaneously activates GLP-1 receptors, GIP receptors, and GCG receptors.
Action pathways:
GLP-1 receptor activation: Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite.
GIP receptor activation: Enhances insulin secretion and improves insulin sensitivity.
GCG receptor activation: Increases energy expenditure, promotes fat burning, and reduces hepatic fat accumulation.
Tirzepatide:
Dual receptor agonist: Activates GLP-1 receptors and GIP receptors.
Mechanism of action:
GLP-1 receptor activation: Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite.
GIP receptor activation: Enhances insulin secretion and improves insulin sensitivity.
► Clinical Efficacy Comparison
Weight Loss Effect:
Retatrutide:
In Phase II clinical trials, the highest dose group (12mg) achieved an average weight loss of 24.2% after 48 weeks.
Its weight loss efficacy significantly outperformed Tirzepatide, particularly among patients requiring substantial weight reduction.
Tirzepatide:
In the SURMOUNT studies, the 15mg dose group achieved an average weight loss of 22.5% at 72 weeks, with 62.9% of patients losing over 20%.
Weight loss effects approached "surgical-level" efficacy but were slightly inferior to Retatrutide.
Glycemic Control:
Retatrutide:
Significantly reduced HbA1c levels, though long-term data remain relatively limited.
Tirzepatide:
In the SURPASS studies, the 15mg dose group achieved a 2.3% HbA1c reduction, outperforming the 1mg semaglutide group's 1.86% reduction.
The proportion reaching HbA1c <7% reached 92% (15mg group), with more extensive long-term glycemic control data available.
Metabolic Marker Improvements:
Retatrutide:
Reduces hypertension, dyslipidemia, and triglyceride levels while improving liver function and cardiovascular risk.
In animal studies, significantly suppressed expression of renal inflammatory factors and fibrotic mediators, enhancing renal function.
Tirzepatide:
Reduces hypertension, dyslipidemia, and triglyceride levels while improving liver function and cardiovascular risk.
In the SURMOUNT studies, significantly reduced visceral fat and improved fatty liver.
► Safety and Side Effect Comparison
Common Side Effects:
Retatrutide:
Gastrointestinal reactions (nausea, vomiting, diarrhea, abdominal pain), typically dose-related, with severity mostly mild to moderate.
Dose-dependent increase in heart rate, peaking early in treatment before gradually decreasing.
Long-term use may lead to tolerance and weight rebound.
Tirzepatide:
Gastrointestinal reactions (nausea, vomiting, diarrhea, constipation), typically occurring during dose escalation and subsequently diminishing.
Injection site reactions, decreased appetite.
Serious Side Effects:
Retatrutide:
Long-term safety requires further study, though animal studies showed no serious adverse reactions.
Tirzepatide:
Risk of hypoglycemia (when used with other antidiabetic agents).
Risk of gallbladder disease and acute pancreatitis.
Risk of medullary thyroid carcinoma (identified in animal studies; human risk remains unclear).
|
|
|
Functions of Peptide-Based Products
Peptide products exert a wide range of effects within the human body through multiple mechanisms, encompassing immune regulation, metabolic balance, tissue repair, and physiological function optimization. Their specific actions are as follows:
► Core Mechanisms of Action
Immune Regulation
Activating Immune Cells: Peptides enhance macrophage phagocytic function, promote T-cell proliferation, and increase total peripheral blood leukocyte counts, thereby boosting the body's defense against viruses and bacteria.
Balancing Endocrine Function: For instance, insulin-like growth factors regulate growth and development, while gonadotropin-releasing hormone participates in reproductive system regulation, helping alleviate endocrine imbalance symptoms.
Metabolic Regulation
Glucose and Lipid Metabolism: Certain peptides assist in lowering blood glucose and cholesterol levels by promoting insulin secretion or inhibiting fat accumulation. For instance, some peptides reduce serum total cholesterol, triglycerides, and LDL cholesterol while increasing HDL cholesterol.
Energy Expenditure: Peptides may activate energy metabolism pathways, promoting fat burning and reducing hepatic fat accumulation.
Tissue Repair and Regeneration
Accelerated Wound Healing: Growth factor peptides (e.g., epidermal growth factor) stimulate cell proliferation and migration. By activating fibroblasts and promoting angiogenesis, they accelerate damaged tissue repair and minimize scar formation.
Bone and Skin Regeneration: Collagen peptides promote skin and bone regeneration, supporting joint health and wound repair.
Antioxidant and Anti-Aging Effects
Free Radical Scavenging: Antioxidant peptides reduce oxidative stress damage to cells, delaying cellular aging processes.
Collagen Synthesis Promotion: Certain peptides stimulate skin collagen production, enhancing elasticity and radiance for a youthful appearance from within.
Neural Signaling
Mood and Sleep Regulation: Neuropeptides (e.g., endorphins) function as neurotransmitters or modulators, transmitting signals to regulate blood pressure, sleep, and emotions while providing analgesic effects and elevating well-being.
► Application Scenarios and Efficacy
Disease Adjuvant Therapy
Diabetes: Insulin peptides assist in lowering blood glucose by promoting insulin secretion.
Osteoporosis: Peptides such as calcitonin regulate calcium metabolism and enhance bone density.
Tumor Therapy: Certain peptide drugs specifically target tumor cells, enhancing treatment efficacy while minimizing damage to healthy tissues.
Chronic Disease Management
Metabolic Syndrome: Peptides regulate glucose and lipid metabolism to help improve symptoms like hypertension and dyslipidemia.
Non-Alcoholic Fatty Liver Disease: Peptides reduce hepatic fat content and improve liver function.
Health Maintenance and Anti-Aging
Daily Nutritional Support: Small-molecule peptides are easily absorbed, rapidly replenishing energy for special populations like post-surgical patients and athletes while promoting physical recovery.
Skin Care: Peptide-infused skincare products stimulate collagen synthesis, provide antioxidant protection, repair the skin barrier, fade pigmentation, and soothe sensitivity. Immune Regulation
Activating Immune Cells: Peptides enhance macrophage phagocytosis, promote T-cell proliferation, and increase peripheral blood leukocyte counts, thereby boosting the body's defense against viruses and bacteria.
Balancing Endocrine Function: For instance, insulin-like growth factors regulate growth and development, while gonadotropin-releasing hormones participate in reproductive system regulation, helping alleviate endocrine imbalance symptoms.
Types of Peptides
Peptide products can be categorized into various types based on their application, source, synthesis method, and functional characteristics, as detailed below:
1) Pharmaceutical Peptides
Hormones: Such as insulin, somatostatin, gonadotropin-releasing hormone, etc., used to regulate blood sugar, growth, and reproductive functions.
Antitumor Peptides: Such as octreotide acetate and thymosin beta-4, which function by inhibiting tumor cell growth or enhancing immunity.
Cardiovascular Peptides: Such as natreptide (for heart failure) and eterabepedil (antiplatelet aggregation).
Metabolic Regulatory Peptides: Such as GLP-1 receptor agonists (liraglutide, semaglutide), used for diabetes treatment.
Peptide Vaccines: Stimulate immune responses by mimicking antigen epitopes, used to prevent diseases like influenza and melanoma.
2) Cosmetic Peptides
Signaling Peptides: e.g., Palmitoyl Pentapeptide-3, promotes collagen synthesis and improves skin elasticity.
Neurotransmitter Inhibitory Peptides: e.g., Acetyl Hexapeptide-8 (botulinum toxin-like), reduces wrinkles.
Carrier Peptides: Such as hyaluronic acid peptides, which enhance skin hydration.
Antimicrobial Peptides: Such as defensins, used to inhibit microbial growth.
3) Functional Food/Health Supplement Peptides
Antioxidant Peptides: Such as soy peptides and oat peptides, which scavenge free radicals and delay aging.
Immune-Modulating Peptides: Such as wheat oligopeptides, which enhance macrophage phagocytic function.
Lipid-Lowering/Hypotensive Peptides: e.g., corn oligopeptides, reduce cholesterol and blood pressure.
4) Research-Grade Peptides
Catalogue Peptides: e.g., angiotensin, ACTH, used in fundamental research.
Modified Peptides: e.g., biotin-labeled peptides, fluorescent-labeled peptides, used for biomarking or imaging.